FDA makes exception for antibody drug conjugates in mass balance studies final guidance
Regulatory NewsFerdous Al-Faruque
Clinical TrialsClinical Trials Regulation ComplianceGuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)